Variant report

Variant	nsv821326
Chromosome Location	chr8:1323056-1324496
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DLGAP2-2	chr8:1322434-1323312	XLOC_006686

Extended variants
information (count: 141 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:141 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs56796572	chr8:1323076-1323077	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs530993357	chr8:1323078-1323079	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
3	rs186021635	chr8:1323100-1323101	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
4	rs566189808	chr8:1323101-1323102	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
5	rs148294383	chr8:1323108-1323109	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
6	rs533350600	chr8:1323116-1323117	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
7	rs577045520	chr8:1323125-1323126	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
8	rs567051125	chr8:1323127-1323128	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs536151011	chr8:1323136-1323137	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs548527822	chr8:1323139-1323140	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs34778497	chr8:1323151-1323152	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs537517239	chr8:1323156-1323157	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs189299945	chr8:1323157-1323158	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs181285394	chr8:1323158-1323159	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs557406550	chr8:1323162-1323163	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs368795759	chr8:1323176-1323177	Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs112083749	chr8:1323251-1323252	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs533738762	chr8:1323257-1323258	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
19	rs141422377	chr8:1323261-1323262	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs62484163	chr8:1323265-1323266	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
21	rs573805441	chr8:1323270-1323271	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
22	rs542960017	chr8:1323295-1323296	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
23	rs62484164	chr8:1323296-1323297	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
24	rs562035510	chr8:1323302-1323303	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
25	rs111919533	chr8:1323306-1323307	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
26	rs111967533	chr8:1323312-1323313	Bivalent Enhancer Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
27	rs375067031	chr8:1323319-1323320	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs575687940	chr8:1323330-1323331	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs185878713	chr8:1323332-1323333	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs113425296	chr8:1323333-1323334	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs60628058	chr8:1323349-1323350	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs57483703	chr8:1323350-1323351	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs71497184	chr8:1323360-1323361	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs60963060	chr8:1323373-1323374	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs370072463	chr8:1323386-1323387	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs540426995	chr8:1323392-1323393	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs560748755	chr8:1323399-1323400	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs71515650	chr8:1323403-1323404	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs374571386	chr8:1323404-1323405	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs529507539	chr8:1323407-1323408	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs57385329	chr8:1323414-1323415	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs58832023	chr8:1323427-1323428	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs113892831	chr8:1323434-1323435	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs376339341	chr8:1323435-1323436	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs549285676	chr8:1323436-1323437	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs569234632	chr8:1323446-1323447	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs77647132	chr8:1323457-1323458	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs74585646	chr8:1323458-1323459	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs551002566	chr8:1323466-1323467	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs56304533	chr8:1323468-1323469	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Autism	20531469	CNVD
Breast cancer	20932292	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:57 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1315800-1336800	Weak transcription	Right Atrium	heart
2	chr8:1320400-1323200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr8:1321400-1323200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr8:1321800-1323200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
5	chr8:1321800-1323400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
6	chr8:1321800-1324400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr8:1322000-1323200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr8:1322000-1323400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
9	chr8:1322000-1324400	Weak transcription	Fetal Brain Female	brain
10	chr8:1322000-1326400	Weak transcription	Spleen	Spleen
11	chr8:1322200-1323200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
12	chr8:1322200-1323200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr8:1322400-1324200	Weak transcription	Fetal Brain Male	brain
14	chr8:1322600-1324200	Weak transcription	Cortex derived primary cultured neurospheres	brain
15	chr8:1322800-1323200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
16	chr8:1322800-1323200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
17	chr8:1322800-1323200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
18	chr8:1322800-1323200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
19	chr8:1322800-1324200	Weak transcription	Brain Anterior Caudate	brain
20	chr8:1323000-1323200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr8:1323000-1323200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr8:1323000-1323200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
23	chr8:1323000-1323200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
24	chr8:1323000-1323200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr8:1323200-1323400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
26	chr8:1323200-1323400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
27	chr8:1323200-1324200	Weak transcription	HUES48 Cell Line	embryonic stem cell
28	chr8:1323200-1324400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr8:1323200-1324400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr8:1323200-1324400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr8:1323200-1324400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
32	chr8:1323200-1326200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr8:1324200-1324400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
34	chr8:1324200-1324400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr8:1324200-1324400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
36	chr8:1324200-1324600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
37	chr8:1324200-1324600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
38	chr8:1324200-1324800	Enhancers	Brain Anterior Caudate	brain
39	chr8:1324200-1324800	Enhancers	Fetal Brain Male	brain
40	chr8:1324200-1325000	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr8:1324200-1325200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
42	chr8:1324200-1325200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
43	chr8:1324200-1325200	Enhancers	Cortex derived primary cultured neurospheres	brain
44	chr8:1324200-1325400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
45	chr8:1324400-1324600	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr8:1324400-1324600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
47	chr8:1324400-1324600	Enhancers	Brain Germinal Matrix	brain
48	chr8:1324400-1324800	Enhancers	H9 Cell Line	embryonic stem cell
49	chr8:1324400-1324800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr8:1324400-1324800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links